JP2008518020A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518020A5
JP2008518020A5 JP2007539081A JP2007539081A JP2008518020A5 JP 2008518020 A5 JP2008518020 A5 JP 2008518020A5 JP 2007539081 A JP2007539081 A JP 2007539081A JP 2007539081 A JP2007539081 A JP 2007539081A JP 2008518020 A5 JP2008518020 A5 JP 2008518020A5
Authority
JP
Japan
Prior art keywords
composition
substance
wound
mammal
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007539081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518020A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/038646 external-priority patent/WO2006047625A2/en
Publication of JP2008518020A publication Critical patent/JP2008518020A/ja
Publication of JP2008518020A5 publication Critical patent/JP2008518020A5/ja
Pending legal-status Critical Current

Links

JP2007539081A 2004-10-27 2005-10-25 創傷治癒を促進する方法 Pending JP2008518020A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62201504P 2004-10-27 2004-10-27
PCT/US2005/038646 WO2006047625A2 (en) 2004-10-27 2005-10-25 Method to promote wound healing

Publications (2)

Publication Number Publication Date
JP2008518020A JP2008518020A (ja) 2008-05-29
JP2008518020A5 true JP2008518020A5 (cg-RX-API-DMAC7.html) 2008-12-04

Family

ID=36228442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007539081A Pending JP2008518020A (ja) 2004-10-27 2005-10-25 創傷治癒を促進する方法

Country Status (6)

Country Link
US (1) US20080318869A1 (cg-RX-API-DMAC7.html)
EP (1) EP1809313A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008518020A (cg-RX-API-DMAC7.html)
AU (1) AU2005299341A1 (cg-RX-API-DMAC7.html)
CA (1) CA2585265A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047625A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101621149B1 (ko) 2014-07-09 2016-05-16 계명대학교 산학협력단 만성 창상용 동물 모델
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
KR101825041B1 (ko) * 2016-04-07 2018-02-02 주식회사 바이오솔루션 물질 p를 포함하는 상처치유용 약학 조성물
WO2018014016A1 (en) * 2016-07-15 2018-01-18 New Amsterdam Sciences Substance and method for treating radiation exposure
JP6901801B2 (ja) * 2017-06-14 2021-07-14 バイオソリューション カンパニー・リミテッドBio Solution Co Ltd 物質pを含むしわの改善または抗炎症化粧料組成物
KR102158969B1 (ko) * 2018-10-19 2020-09-23 주식회사 바이오솔루션 물질 p를 포함하는 난치성 궤양 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616562A (en) * 1990-04-27 1997-04-01 Murphy; Christopher J. Methods and compositions using substance P to promote wound healing
US5945508A (en) * 1996-07-23 1999-08-31 Witten; Mark L. Substance P treatment for immunostimulation
JP4096115B2 (ja) * 2000-08-10 2008-06-04 輝夫 西田 皮膚創傷治癒促進剤
AU7776701A (en) * 2000-08-10 2002-02-25 Santen Pharmaceutical Co Ltd Skin wound healing promoters
US20060153789A1 (en) * 2002-12-18 2006-07-13 Witten Mark L Stimulation of hair regrowth
US20070154448A1 (en) * 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing

Similar Documents

Publication Publication Date Title
ES2811087T3 (es) Uso de agonistas de PPAR-delta para tratar la atrofia muscular
Snyder et al. Effect of mepivacaine in an infraorbital nerve block on minimum alveolar concentration of isoflurane in clinically normal anesthetized dogs undergoing a modified form of dental dolorimetry
JP2004535473A5 (cg-RX-API-DMAC7.html)
CN114106100B (zh) 用于修复皮肤创伤或黏膜损伤的多肽及其应用
ES2327640T3 (es) Sustancias biologicamente activas a partir de un peptido intestinal vasoactivo para el tratamiento de afecciones pulmonares intersticiales.
JP5823486B2 (ja) 放射線および熱の複合損傷の治療方法
Kollias et al. Procyonids and mustelids
Sayce et al. Continuous rate infusion of ketamine hydrochloride and dexmedetomidine for maintenance of anesthesia during laryngotracheal surgery in New Zealand White Rabbits (Oryctolagus cuniculus)
CN116076438A (zh) 类风湿关节炎合并间质性肺病动物模型及其构建方法和应用
JP2019508416A (ja) 術後認知機能障害の処置のための方法及び医薬組成物
KR20110038139A (ko) 폴리오르소에스테르 및 이의 제형의 안정성 강화 방법
Larouche et al. Effects of midazolam and nitrous oxide on the minimum anesthetic concentration of isoflurane in the ball python (Python regius)
Klide et al. Chemical restraint of three reptilean species
CN110548132A (zh) TGF-β1蛋白在制备治疗抑郁症的药物中的应用
CN108697758B (zh) 用于有效控制急性和/或慢性疼痛的药物及其施用方法
JP2008518020A (ja) 創傷治癒を促進する方法
CN113855676A (zh) Ad16在制备减轻慢性炎症痛药物中的应用
CN101309694B (zh) 通过诱导免疫耐受治疗纤维化疾病的方法
RU2780544C1 (ru) Способ моделирования пародонтита
Blackburn et al. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation
Bennett et al. Surgical management of bifid sternum in two African grey parrots
Ziv et al. The Use of an Advancement Flap to Manage a Chronic Skin Lesion in a Laying Hen (Gallus gallus domesticus)
CN118436621A (zh) 一种辣椒素电极片
Gopinathan et al. Treatment of old non-healing wounds in equines with homeopathic drugs
Ghamsari et al. Evaluation of topical use of estrogen hormone on open wound healing in horses